In sum, deep immune profiling of TEX using mass cytometry is expected to provide further insights into the biology underlying this special T cell differentiation stage and its role in pathogenesis and response to immune therapies in cancer, viral infection and autoimmunity. The gene discussed is TEX46; the disease is cancer.